1616930-45-0

Basic information

• Product Name: methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate
• Synonyms: methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate
• CAS NO: 1616930-45-0
• Molecular Weight: 266.105
• Mol File: 1616930-45-0.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate(1616930-45-0)
• EPA Substance Registry System: methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate(1616930-45-0)

Safety Data

• Hazardous Substances Data: 1616930-45-0(Hazardous Substances Data)

Upstream product

• 17827-61-1 methyl ester of 1-methylpyrazole-3-carboxylic acid 
• 25015-63-8 4,4,5,5-tetramethyl-[1,3,2]-dioxaboralane 
• 15366-34-4 methyl 1H-pyrazole 3-carboxylate 

Downstream Products

• 1616930-47-2 C₁₃H₁₃ClN₂O₃ 
• 1616929-90-8 5-(5-cyclopropyl-2-methoxy-phenyl)-N-(3-fluoro-pyridin-4-yl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1616929-92-0 5-(2-Cyclopropyl-5-methyl-pyrimidin-4-yl)-A/-(2,6-difluoro-phenyl)-1-methyl-1H-pyrazole-3-carboxylic acid amide 
• 1616930-48-3 C₁₆H₁₈N₂O₃ 

Relevant articles and documents

NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS

Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

PRC2 INHIBITORS

The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention. (Formula (I))

PYRAZOLYL-BASED CARBOXAMIDES I AS CRAC CHANNEL INHIBITORS

The Invention relates to pyrazolyl-based carboxamide compounds of formula (l) useful as ICRAC inhibitors, to pharmaceutical compositions containing these compounds and to these compounds for the use in the treatment and/or prophylaxis of diseases and/or disorders, in particular inflammatory diseases and/or inflammatory disorders.